| Identification | Back Directory | [Name]
N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-
fluoro-4-[2-methyl-3-(propan-2-yl)-2H-indazol-5-yl]
pyrimidin-2-amine | [CAS]
1868086-40-1 | [Synonyms]
Eciruciclib
inhibit,CDK,Cyclin dependent kinase,Eciruciclib,Inhibitor
N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-
fluoro-4-[2-methyl-3-(propan-2-yl)-2H-indazol-5-yl]
pyrimidin-2-amine
2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[2-methyl-3-(1-methylethyl)-2H-indazol-5-yl]- | [Molecular Formula]
C27H33FN8 | [MDL Number]
MFCD32879004 | [MOL File]
1868086-40-1.mol | [Molecular Weight]
488.6 |
| Chemical Properties | Back Directory | [Boiling point ]
682.6±65.0 °C(Predicted) | [density ]
1.28±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [form ]
Solid | [pka]
7.69±0.10(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
Eciruciclib is an antineoplastic and potent cyclin dependent kinase (CDK) inhibitor[1]. | [References]
[1] WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022. |
|
|